Organization: New York Stem Cell Foundation
Personal Biography: Dr. Stephen Chang joined NYSCF in 2010 as the Vice President of Research and Development after serving as Chief Scientific Officer of Stemgent upon the company’s founding in 2008. He was previously the CEO of Multicell Technologies and continues as a director of this company. Prior to that, he was the CEO of Astral Immunotherapy which was acquired by Multicell Technologies in 2005. Previously, he was chief science officer (CSO) and vice president of Canji Inc. / Schering Plough Research Institute in San Diego from 1998 to 2004. He has also held senior management positions at Chiron and Viagene.
Lecture Topic: The Science of Stem Cells: A Personal Journey as a Geneticist
When it comes to the future, there are three kinds of people: those who let it happen, those who make it happen, and those who wonder what happened. Science is not a “spectator sport”. Stem cell science is truly a “participatory sport” in all walks of life. Stem Cells are important medical tools in the treatment of disease already. Future work offers unlimited possibilities which Dr. Chang will discuss. Every great advance in science has issued from a new audacity of imagination. Reprogramming is the ability to convert almost any cell into a stem like cell. Yamanaka and colleagues showed that in 2006 that this was possible with mouse cells. In 2007 other groups showed that you could do this with human cells. Dr. Chang will discuss how the field is moving today. The best way to predict the future is to invent it. This is the most exciting time in biology. We know 0.01% of the knowledge on how systems work. Stem Cells are one such system. Understanding how a pluripotent cell becomes a differentiated cell is the next frontier. In addition, Dr. Chang will also briefly discuss his career and the way it has benefited society.